| 000 | 01886 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514024249.0 | ||
| 264 | 0 | _c20020423 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.2002.01173.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeitz, Ulrich | |
| 245 | 0 | 0 |
_aHigh rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cFeb 2002 |
||
| 300 |
_a315-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBreath Tests |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitroimidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSulliga, M | |
| 700 | 1 | _aWolle, K | |
| 700 | 1 | _aLeodolter, A | |
| 700 | 1 | _aVon Arnim, U | |
| 700 | 1 | _aKahl, S | |
| 700 | 1 | _aStolte, M | |
| 700 | 1 | _aBörsch, G | |
| 700 | 1 | _aLabenz, J | |
| 700 | 1 | _aMalfertheiner, P | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 16 _gno. 2 _gp. 315-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2002.01173.x _zAvailable from publisher's website |
| 999 |
_c11768373 _d11768373 |
||